SEC 13F Intelligence

Fairmount Funds Management LLC / APGE

Fairmount Funds Management LLC’s Apogee Therapeutics Inc Com Position

Does Fairmount Funds Management LLC own Apogee Therapeutics Inc Com (APGE)? Yes — 298.6K shares worth $25M (+1.82% of its 13F portfolio) as of Q1 2026, down from 2.05M shares the prior filed quarter.

Position Value
$25M
Q1 2026
Shares
298.6K
% of Portfolio
+1.82%
Quarters Held
11
currently held

Position History APGE

Reported value by quarter
Q3 ’23: $63MQ3 ’23Q4 ’23: $82MQ1 ’24: $136MQ1 ’24Q2 ’24: $81MQ3 ’24: $120MQ3 ’24Q4 ’24: $93MQ1 ’25: $77MQ1 ’25Q2 ’25: $89MQ3 ’25: $81MQ3 ’25Q4 ’25: $155MQ1 ’26: $25MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026298.6K$25M+1.82%
Q4 20252.05M$155M+11.77%
Q3 20252.05M$81M+7.32%
Q2 20252.05M$89M+11.53%
Q1 20252.05M$77M+11.87%
Q4 20242.05M$93M+9.23%
Q3 20242.05M$120M+9.76%
Q2 20242.05M$81M+9.11%
Q1 20242.05M$136M+14.84%
Q4 20232.94M$82M+8.68%
Q3 20232.94M$63M+7.54%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Fairmount Funds Management LLC’s full portfolio or all institutional holders of APGE.